The "Integrated Health Service System for Prevention Treatment and Rehabilitation of Major and Chronic Diseases through the Synergy of Traditional Chinese and Western Medicine" - Research and Health Management Project on the Prevention and Treatment of "Lung and Kidney Deficiency" Symptom Complex with Bailing Capsules

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ITMCTR

Registry ID

ITMCTR2025001022

Enrollment

Unknown

Registered

2025-05-23

Start date

2025-05-31

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly frail population with lung deficiency/kidney deficiency/both lung and kidney deficiency syndrome

Interventions

exposure group:Use Bailing Capsules (manufacturer: Hangzhou Zhongmei Huadong Pharmaceutical Co. Ltd.) and do not use other similar traditional Chinese medicines.

Non exposed group:Do not use Bailing capsules and other similar traditional Chinese medicines

Registration and filing:NA

Eligibility

Sex/Gender

All

Age

60 Years to 100 Years

Inclusion criteria

Inclusion criteria: Registration of research subjects Elderly frail individuals who meet the criteria of lung deficiency/kidney deficiency/both lung and kidney deficiency. Prospective cohort study subjects Elderly frail individuals with moderate to severe lung and kidney qi deficiency syndrome.

Exclusion criteria

Exclusion criteria: Not Applicable

Design outcomes

Primary

Measure	Time frame
Changes in Health Survey Summary Table (SF-12);Effective rate/change value of core symptoms of lung and kidney qi deficiency in elderly patients with weakness;	—

Countries

China

Contacts

Public ContactBing Mao

West China Hospital of Sichuan University

maobing@medmail.com.cn18980601724

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026